Stryker Corporation (NYSE:SYK) Shares Sold by Forte Capital LLC ADV

Forte Capital LLC ADV decreased its stake in Stryker Corporation (NYSE:SYK - Free Report) by 19.7% in the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 4,280 shares of the medical technology company's stock after selling 1,050 shares during the quarter. Forte Capital LLC ADV's holdings in Stryker were worth $1,593,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Brighton Jones LLC boosted its holdings in Stryker by 15.4% during the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company's stock valued at $1,643,000 after acquiring an additional 609 shares during the period. Proficio Capital Partners LLC boosted its holdings in Stryker by 46.2% during the 4th quarter. Proficio Capital Partners LLC now owns 1,656 shares of the medical technology company's stock valued at $596,000 after acquiring an additional 523 shares during the period. Creative Financial Designs Inc. ADV boosted its holdings in Stryker by 25.6% during the 4th quarter. Creative Financial Designs Inc. ADV now owns 398 shares of the medical technology company's stock valued at $143,000 after acquiring an additional 81 shares during the period. Cozad Asset Management Inc. boosted its holdings in Stryker by 5.5% during the 4th quarter. Cozad Asset Management Inc. now owns 888 shares of the medical technology company's stock valued at $320,000 after acquiring an additional 46 shares during the period. Finally, PDS Planning Inc boosted its holdings in Stryker by 9.8% during the 4th quarter. PDS Planning Inc now owns 1,562 shares of the medical technology company's stock valued at $562,000 after acquiring an additional 140 shares during the period. Hedge funds and other institutional investors own 77.09% of the company's stock.

Analyst Ratings Changes

A number of research firms recently issued reports on SYK. BTIG Research restated a "buy" rating on shares of Stryker in a report on Monday. Wall Street Zen cut Stryker from a "buy" rating to a "hold" rating in a report on Friday, June 27th. Truist Financial upped their target price on Stryker from $390.00 to $400.00 and gave the stock a "hold" rating in a report on Monday, May 5th. Roth Mkm boosted their price target on Stryker from $405.00 to $456.00 and gave the stock a "buy" rating in a research report on Friday, May 2nd. Finally, Needham & Company LLC reissued a "buy" rating and issued a $442.00 price target on shares of Stryker in a research report on Friday, March 21st. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. Based on data from MarketBeat, Stryker presently has a consensus rating of "Moderate Buy" and an average target price of $428.55.

Insider Buying and Selling at Stryker

In related news, Director Ronda E. Stryker sold 200,000 shares of the firm's stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the sale, the director directly owned 3,417,326 shares of the company's stock, valued at $1,288,195,208.96. This trade represents a 5.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 5.90% of the company's stock.

Stryker Stock Performance

Stryker stock traded down $1.85 during trading hours on Thursday, hitting $389.02. 1,039,855 shares of the stock traded hands, compared to its average volume of 1,352,593. The firm's 50 day moving average price is $385.38 and its 200-day moving average price is $377.55. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.64 and a quick ratio of 1.00. The stock has a market capitalization of $148.49 billion, a price-to-earnings ratio of 52.57, a P/E/G ratio of 2.95 and a beta of 0.91. Stryker Corporation has a 1 year low of $314.93 and a 1 year high of $406.19.

Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.84 earnings per share for the quarter, beating analysts' consensus estimates of $2.73 by $0.11. The business had revenue of $5.87 billion for the quarter, compared to analyst estimates of $5.68 billion. Stryker had a return on equity of 23.74% and a net margin of 12.31%. The company's revenue was up 11.9% on a year-over-year basis. During the same period in the prior year, the company earned $2.50 earnings per share. As a group, equities analysts expect that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Monday, June 30th will be issued a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.86%. The ex-dividend date is Monday, June 30th. Stryker's dividend payout ratio is presently 45.41%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.